NCT00431782 - Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

October 31, 2007

Conditions

Atrial Fibrillation

Interventions

DRUG

ATI-5923

Trial Locations (11)

ARYx Investigational Site, Anaheim

ARYx Investigational Site, Yuba City

ARYx Investigational Site, Deerfield Beach

ARYx Investigational Site, Winfield

ARYx Investigational Site, Oklahoma City

ARYx Investigational Site, Wellsboro

ARYx Investigational Site, Wynnewood

ARYx Investigational Site, Greer

ARYx Investigational Site, Spartanburg

ARYx Investigational Site, Memphis

ARYx Investigational Site, San Antonio